KCT0006764尚未招募未知
A study on the safety and effectiveness of one-arm motorized gait training device for gait rehabilitation on the hemiplegic disabled due to stroke
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20?(Year) 至 80?(Year)（—）
- 性别
- All
入选标准
- •· A sub-acute period between 25 days (about 4 weeks) and 180 days (6 months) after onset or 181 days (6 months) to 2,350 days (about 6 years and 5 months) after onset.
- •· A person who has stable vital signals such as blood pressure and pulse.
- •· A person who has no communication problem with a simple mental health test score of 24 or higher.
- •· Those with a functional gait assessment of 3 or less (a level that requires intermittent help from one person or auxiliary tools to help balance or coordination).
排除标准
- •· A person who has a problem or disease in the nervous system or musculoskeletal system other than stroke.
- •· A person who is taking drugs that can affect balance or walking.
研究者
相似试验
进行中（未招募）
不适用
A study to assess the efficacy and safety of oral rigosertib in patients with myelodysplastic syndrome (a blood disease) who are dependent on transfusions.MedDRA version: 14.1Level: PTClassification code 10028533Term: Myelodysplastic syndromeSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Myelodysplastic SyndromeEUCTR2013-000672-15-FROnconova Therapeutics, Inc.40
已完成
不适用
A single arm study to assess the efficacy and safety of high dose intake of food containing aged garlic extract on fatigueHealthy volunteerJPRN-UMIN000029109Momoya Co., Ltd.10
已完成
3 期
Female patients PCOS with associated symptoms of mild to moderate acne and hirsutismCTRI/2018/03/012481Curatio Health Care I Pvt Ltd30
招募中
2 期
Single arm study to evaluate the efficacy and safety of Relugolix in adenomyosisJPRN-jRCTs031220684Hirota Yasushi20
进行中（未招募）
1 期
A research study looking at how safe somapacitan is and how well it works in children who need help to grow – REAL 9CTIS2022-501055-87-01ovo Nordisk A/S44